advisorsecurities master

RNACCartesian Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
21059
Ticker
RNAC
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2016-06-22
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
RNAC

Detail

Enriched 2026-08-14 20:47

Market cap
$262,465,178.6
Shares outstanding (class)
30,255,352
Shares outstanding (weighted)
30,255,352
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
75
Location
FREDERICK, MD
Description

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data